Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.11 $15.83 Friday, 10th May 2024 SRRK stock ended at $13.35. This is 8.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.97% from a day low at $13.19 to a day high of $14.37.
90 days $12.81 $17.90
52 weeks $5.56 $21.17

Historical Scholar Rock Holding Corp. prices

Date Open High Low Close Volume
Feb 29, 2024 $17.15 $17.15 $15.36 $15.50 953 385
Feb 28, 2024 $17.33 $17.61 $16.69 $16.78 932 590
Feb 27, 2024 $16.20 $17.40 $16.16 $17.08 815 866
Feb 26, 2024 $15.52 $16.03 $15.44 $15.86 789 769
Feb 23, 2024 $15.73 $16.04 $15.46 $15.60 349 409
Feb 22, 2024 $14.80 $15.69 $14.72 $15.63 418 068
Feb 21, 2024 $14.58 $15.24 $14.50 $14.98 942 284
Feb 20, 2024 $15.70 $16.05 $14.70 $15.01 313 023
Feb 16, 2024 $15.75 $16.09 $15.47 $15.87 425 847
Feb 15, 2024 $15.75 $15.87 $15.16 $15.77 386 178
Feb 14, 2024 $15.58 $15.59 $15.07 $15.50 467 976
Feb 13, 2024 $14.29 $15.53 $14.00 $15.35 595 512
Feb 12, 2024 $15.51 $15.93 $15.29 $15.75 519 137
Feb 09, 2024 $15.77 $16.17 $15.35 $15.40 411 721
Feb 08, 2024 $16.10 $16.34 $15.69 $15.71 291 860
Feb 07, 2024 $15.92 $16.21 $15.55 $16.02 406 861
Feb 06, 2024 $15.46 $16.55 $15.38 $15.97 562 744
Feb 05, 2024 $14.84 $15.31 $14.38 $15.29 317 648
Feb 02, 2024 $14.79 $15.14 $14.49 $15.06 443 388
Feb 01, 2024 $14.08 $15.03 $14.00 $14.94 561 519
Jan 31, 2024 $14.32 $14.50 $13.89 $13.95 466 950
Jan 30, 2024 $15.06 $15.12 $14.09 $14.36 383 161
Jan 29, 2024 $14.68 $15.23 $14.33 $15.16 415 053
Jan 26, 2024 $14.99 $15.35 $14.48 $14.61 308 844
Jan 25, 2024 $14.97 $15.50 $14.76 $14.91 440 870
Click to get the best stock tips daily for free!

About Scholar Rock Holding Corp.

Scholar Rock Holding . Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria... SRRK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT